Top 5 Takeaways From the CMS 2023 Final Rule: Conversion Factor, MIPS, Telehealth, E/M, and Refunds for Discarded Drugs

Why This Topic Matters

CMS final rules often influence Medicare policy and can shape commercial payer behavior, internal charge structures, compliance workflows, and documentation practices. Understanding the broad scope of these changes helps organizations prepare for operational and reimbursement impacts.

Article Sections

1. Introduction and rulemaking context

   Provides background on the CMS annual final rule process and the role of public comments. It also frames the article as a selective overview of major policy areas rather than a full summary of the entire rule.

2. Conversion Factor

   Discusses a Medicare Physician Fee Schedule payment update and its operational implications for fee schedules and reimbursement planning.

3. MIPS Program

   Covers updates related to quality reporting under MIPS, including pathway structure and timing considerations for performance measurement.

4. Telehealth

   Reviews telehealth-related flexibilities tied to the public health emergency, including service location considerations, eligible provider types, and temporary policy extensions.

5. Evaluation and Management (E/M) Services

   Summarizes E/M-related documentation and guideline updates, including changes affecting time-based reporting and split/shared services.

6. Refunds for Discarded Single Dose Drugs

   Describes a policy area involving discarded drug refunds, along with related enforcement and dispute-resolution topics.

7. Additional 2023 updates

   Mentions other broad CMS updates referenced by the article, including behavioral health, preventive services, and opioid treatment program topics.